Stocks · News reference
Apogee (APOG) stock surges after Q1 2027 earnings and revenue beat Wall Street estimates. Read the full financial breakdown here.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
AbbVie (NYSE:ABBV) today announced that it expects its acquisition of Apogee to negatively impact adjusted diluted earnings per share (EPS) by $0.14 in 2026 (partial year) and approximately $0.46 in 2027, with accretion
Filed: 2026-09-03 AccNo: 0000006845-26-000087 Size: 24 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Apogee Enterprises, Inc. (NASDAQ:APOG), a leading provider of architectural building products and services, as well as high-performance coated materials used in a variety of applications, announced today that it has
U.S. stocks slightly up, Dow Jones gains 0.1%. Health care shares jump 2.8%, ON Semiconductor down 20%. Oil down 4%, gold up 1.2%, eurozone and Asian markets closed lower.